Table 1.
Mouse model |
Antigen specificity |
Developmental blockade |
Lifespan | Phenotype in basal state |
Outcomes of BCR aggregation (IgM-specific antibody) |
Outcomes of TLR ligation |
Refs |
---|---|---|---|---|---|---|---|
MD4× ML5 |
HEL | Yes, at T3 B-cell stage |
Short | IgMlow, CD86low, high intracellular Ca2+, high ERK phosphorylation |
|
|
5,6,7,36 |
VH3H9× Vλ2 |
dsDNA | Yes, at immature B-cell stage |
Short | IgMmid, CD80–, CD86– ,↑HSA, TCD44, ↑MHC class II |
|
|
12,13 |
VH3H9× Vκ8 |
ssDNA | No | Normal | Normal |
|
|
12,14 |
VH125 × Vκ125 |
Insulin | No | Normal | Normal |
|
|
26,61 |
VH2–12 | ssDNA, Sm | Yes, at pre- plasma-cell stage |
Normal or short |
↑CD80, ↑CD40, ↑ CD44, slight increase in ERK phosphorylation |
|
|
21,22 |
VH2–12× Vκ8 |
Sm | No | Normal | ↑CD95, ↑MHC class II, IgMmid |
|
|
24,53 |
Ars/A1 | ssDNA | Yes, at T3 B-cell stage |
Short (in vitro) |
IgMmid, CD80hi, CD95hi MHC class IIhi, high intracellular Ca2+, high ERK phosphorylation |
|
|
28,30 |
An1 | Mixed | Yes, at T3 B-cell stage |
Short | ND |
|
|
29 |
Evidence suggests that this only occurs if in vitro cultures are free of dendritic cells and macrophages53. BCR, B-cell receptor; dsDNA, double-stranded DNA; ERK, extracellular-signal-regulated kinase; HEL, hen-egg lysozyme; HSA, heat-stable antigen; ND, not determined; Sm, Smith antigen; ssDNA, single-stranded DNA; SYK, spleen tyrosine kinase; T3, transitional 3; TLR, Toll-like receptor.